Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Increased Domestic Options Pave Way for New SHARx Stormproof Solution


      News provided by

      SHARx

      Nov 19, 2026, 08:05 ET

      Share this article

      Share this article


      Recent federal import changes are raising questions about prescription access and sourcing options. SHARx CEO Corey Durbin says the company's new Stormproof program is designed to help employers and members navigate uncertainty through expanded sourcing flexibility, prescription advocacy, and additional healthcare support.

      ST. LOUIS, Nov. 19, 2026 /PRNewswire/ -- Recent media coverage and evolving federal import requirements have drawn renewed attention to prescription sourcing and continuity of access. The news, changing policies, and shifting implementation deadlines have prompted questions from employers and benefits brokers about their sourcing options. The industry experts at SHARx, a supply-chain and procurement management company, have answers.

      Continue Reading
      "Stormproof reflects how we respond: stay prepared, adapt as conditions change, and keep working with employers and members to find the fastest path forward through the storm.”
      "Stormproof reflects how we respond: stay prepared, adapt as conditions change, and keep working with employers and members to find the fastest path forward through the storm.”

      "Employers and brokers are right to ask what these developments mean for the people who rely on prescriptions, especially high-priced specialty pharmaceuticals," said Corey Durbin, Chief Executive Officer and Co-founder of SHARx. "But the problem is getting worse as high-cost drugs (those that cost more than $4,000 per year) spending has doubled what it was in 2017. Our response has been in development for months."

      Stormproof emanated from a full review of all member medications. The increase in domestic sourcing options has made the inception of Stormproof possible and will shield employers and members from sourcing uncertainty.

      "Stormproof is built around a full analysis of the domestic options and a determination that the value we bring to members and employers can be even greater than it has been. It gives our organization more ways to help members access the medications they need as sourcing conditions change. In this business, the operating conditions can change like the weather. It's an atmosphere that has always driven us to be a highly responsive organization," Durbin said.

      Preparing for Changing Requirements

      Recent headlines, including a November 11, 2026, CNBC report detailing a federal arrest of a top healthcare company official accused of illegal drug importation through an alternative funding program (AFP), come on the heels of Federal agencies announcing changes affecting customs procedures. First, a U.S. Customs and Border Protection (CBP) rule established new requirements for foreign importers of record, the parties legally responsible for declaring imported goods to CBP, takes effect January 5, 2027. Separately, CBP moved the mandatory implementation date for its Entry Type 13 process, an electronic filing process for certain international mail shipments, from October 22, 2026, to January 20, 2027.

      The requirements address different customs processes. Their specific effects on individual prescription pathways may depend on how a shipment is handled and on applicable agency requirements. Durbin said SHARx's policy and operations teams have been preparing for the changes and evaluating options to help members maintain access to their medications while minimizing potential disruptions.

      "Policy changes create uncertainty for all stakeholders, but the need for affordable specialty medication is not going away," said Paul Pruitt, Chief Growth Officer and Co-founder of SHARx. "Our role is to understand what is changing, help employers and members assess their options, and keep working on ways to support both."

      A Flexible Approach to Prescription Access

      Stormproof is designed to support members with affordable options, depending on the member or employer preference, member circumstances, and applicable requirements. Durbin says SHARx is still committed to assisting members, most able to obtain their medications at no cost, regardless of sourcing pathways. Employers can choose from two different financial models – both with significant upside to the employer.

      The program also includes additional member support designed to complement prescription assistance. These include AI-enhanced mental health and wellness support, 24/7 virtual primary care, and a very affordable weight-loss option that helps replace a benefit many employers had to cut out because of cost.

      "Employees need affordable access but should not have to depend on a single sourcing pathway to help them manage high-cost medications," Durbin said. "Stormproof gives us a broader framework to assist employers and members as circumstances change, while keeping affordability and access at the center of our plans."

      SHARx has worked with employer-sponsored health plans since 2017 to help address the financial impact of high-cost prescription drugs, while adhering to the highest standards of member access and support. The company says it will continue to monitor policy developments and provide clients with updates as it operationalizes Stormproof.

      "Storms are part of this landscape, but too many try and run from the storm instead of through it. Stormproof reflects how we respond: stay prepared, adapt as conditions change, and keep working with employers and members to find the fastest path forward through the storm." Durbin said.

      About SHARx

      SHARx is a procurement and supply chain management solution for high-cost prescription drugs. Working alongside employer-sponsored health plans, SHARx helps employers address the financial impact of expensive and specialty medications while providing members with personalized advocacy and access to cost-effective sourcing solutions. Learn more at SHARx.com.  

      References:

      • U.S. Customs and Border Protection. (2026, November 6). Heightened requirements for foreign importers of record. Federal Register, 91(214), 69977–70007. govinfo.gov/content/pkg/FR-2026-11-06/html/2026-22735.htmgovinfo.gov
      • U.S. Customs and Border Protection. (2026, October 14). International mail Entry Type 13 mandatory implementation date extended to Jan. 20, 2027 [News release]. content.govdelivery.com/accounts/USDHSCBP/bulletins/42f29b6
      • Zamost, S. (2026, November 11). Feds arrest top official of healthcare company, alleging illegal drug importation. CNBC. cnbc.com/2026/11/11/canarx-official-arrested-drug-importation.html

      Media inquiries:
      Karla Jo Helms
      JOTO PR™
      727-777-4629
      Jotopr.com

      SOURCE SHARx

      Modal title

      Also from this source

      One Prescription Can Rewrite the Benefits Budget, SHARx Warns

      One Prescription Can Rewrite the Benefits Budget, SHARx Warns

      Many new prescriptions come with price tags that can eat up a large part of an employer's annual healthcare forecast. For self-funded employers,...

      Patent Expiration Does Not Signal a Savings Date, Cautions SHARx's Paul Pruitt

      Patent Expiration Does Not Signal a Savings Date, Cautions SHARx's Paul Pruitt

      A drug nearing patent expiration may seem like relief from high prices, but lower-cost competition can still take years to reach the market....

      More Releases From This Source

      Explore

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Pharmaceuticals

      Pharmaceuticals

      Health Care & Hospitals

      Health Care & Hospitals

      Computer & Electronics

      Computer & Electronics

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.